TOP TIERMARKET NEWSWIRE
Movers explained · October 28, 2026

Why Is XENCOR INC (XNCR) Stock Moving Today?

By the Top Tier Newswire AI Desk · September 2, 2026 at 12:45 PM ET · reviewed against 10 wire stories

XENCOR INC (XNCR) is drawing unusual attention today. Our newswire has captured 10 stories on XNCR across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 64/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

XNCR stock fell 5.27% to $26.44 in early trading on Tuesday as the shares declined from a morning high of $28.98 to a session low of $26.42. The move came despite recent analyst activity that raised price targets for the stock. The stock traded at a discount to its 52-week high of $30.61 and was near the bottom of its 52-week range.

What Happened

The stock opened at $27.94 and saw a brief rally before declining throughout the session. The price drop followed a series of analyst upgrades and higher price targets from Raymond James, RBC Capital, Wedbush, and Cantor Fitzgerald. Raymond James raised its price target to $46 from $40, while RBC Capital raised its target to $20, Wedbush to $30, and Cantor Fitzgerald to $44. These moves occurred alongside Xencor’s Q2 results, which showed an EPS of $(0.29), beating estimates, and revenue of $51.200M, also exceeding forecasts. However, the stock’s decline suggests investors may be reacting to broader market conditions or internal selling pressure.

What The Data Shows

The stock traded at 0.2M shares, or 0.2 times its 3-month daily average, indicating limited participation. Xencor remains unprofitable with a TTM net margin of -155.6% and a TTM revenue decline of 28.6%. The stock has a beta of 0.84, slightly less volatile than the market. Recent insider transactions show five sales totaling $379K in the last 90 days, with the most recent sale on June 22, 2026. The stock also printed 32 fresh 52-week lows on September 2, 2026, highlighting its weak relative performance.

What To Watch

Investors should monitor the stock’s next earnings report, if scheduled, and continue tracking analyst coverage and insider activity for further signals.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

XNCR by the numbers

7 sessions: +31.25%Coverage: 10 stories / 4 sourcesAI sentiment: 64/100 (bullish)Mkt cap: $2.0B52w: $7.91 to $30.61
XNCR · Oct 26 session (5-min) · +26.33% vs prior close · updated 9:45 AM ET
$24.58$30.15$35.71prev close $25.18$31.817:00 AM7:41 AM8:22 AM9:03 AM9:45 AM7:00 AM · $32.517:05 AM · $34.197:10 AM · $33.007:15 AM · $32.837:20 AM · $33.237:25 AM · $33.987:30 AM · $35.127:35 AM · $34.537:40 AM · $35.037:45 AM · $34.257:50 AM · $33.957:55 AM · $33.048:00 AM · $33.048:05 AM · $33.168:10 AM · $33.678:15 AM · $33.288:20 AM · $33.278:25 AM · $33.098:30 AM · $33.068:35 AM · $33.068:40 AM · $33.518:45 AM · $33.728:50 AM · $33.508:55 AM · $33.229:00 AM · $33.069:05 AM · $32.509:10 AM · $32.639:15 AM · $32.439:20 AM · $32.609:25 AM · $32.199:30 AM · $32.459:35 AM · $31.889:40 AM · $31.859:45 AM · $31.81
AI sentiment, last 36h · averaged over 10 stories · 64/100 bullish
AI sentiment 64/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 10 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agonowInvesting.com Analyst Ratings · sentiment 64 · Wells Fargo raises Xencor stock price target on kidney cancer dataInvesting.com Analyst Ratings · 64Wells Fargo raises Xencor stock price target on kidney cancer dataThe Fly · sentiment 67 · Xencor price target raised to $45 from $30 at WedbushThe Fly · 67Xencor price target raised to $45 from $30 at WedbushThe Fly · sentiment 64 · Xencor price target raised to $40 from $29 at TruistThe Fly · 64Xencor price target raised to $40 from $29 at TruistThe Fly · sentiment 64 · Xencor Price Target Raised To 40 From 29 At Truist Thefly News 2The Fly · 64Xencor Price Target Raised To 40 From 29 At Truist Thefly News 2Seeking Alpha · sentiment 58 · Xencor, Inc. (XNCR) Discusses Phase 1 XmAb819 Results in Advanced Clear Cell Renal Cell Carcinoma - SlideshowSeeking Alpha · 58Xencor, Inc. (XNCR) Discusses Phase 1 XmAb819 Results in Advanced Clear Cell Renal Cell C…The Fly · sentiment 74 · Xencor price target raised to $43 from $20 at RBC CapitalThe Fly · 74Xencor price target raised to $43 from $20 at RBC CapitalGuruFocus · sentiment 63 · XNCR Maintained by Wedbush -- Price Target Raised to $45GuruFocus · 63XNCR Maintained by Wedbush -- Price Target Raised to $45GuruFocus · sentiment 63 · Xencor (XNCR) Maintained by RBC Capital -- Price Target Raised to $43.00GuruFocus · 63Xencor (XNCR) Maintained by RBC Capital -- Price Target Raised to $43.00GuruFocus · sentiment 63 · XENCOR Maintained by Wells Fargo -- Price Target Raised to $44.00GuruFocus · 63XENCOR Maintained by Wells Fargo -- Price Target Raised to $44.00GuruFocus · sentiment 64 · XENCOR Maintains Buy Rating -- Price Target Raised to $40.00 by Truist SecuritiesGuruFocus · 64XENCOR Maintains Buy Rating -- Price Target Raised to $40.00 by Truist Securities
22h agoGuruFocusBULLISH 64Analyst

XENCOR Maintains Buy Rating -- Price Target Raised to $40.00 by Truist Securities

1d agoGuruFocusBULLISH 63Analyst

XENCOR Maintained by Wells Fargo -- Price Target Raised to $44.00

1d agoGuruFocusBULLISH 63Analyst

Xencor (XNCR) Maintained by RBC Capital -- Price Target Raised to $43.00

1d agoGuruFocusBULLISH 63Analyst

XNCR Maintained by Wedbush -- Price Target Raised to $45

1d agoThe FlyBULLISH 74Analyst

Xencor price target raised to $43 from $20 at RBC Capital

1d agoSeeking AlphaBULLISH 58Product/PR

Xencor, Inc. (XNCR) Discusses Phase 1 XmAb819 Results in Advanced Clear Cell Renal Cell Carcinoma - Slideshow

2026-10-27. The following slide deck was published by Xencor, Inc.

1d agoThe FlyBULLISH 64Analyst

Xencor Price Target Raised To 40 From 29 At Truist Thefly News 2

1d agoThe FlyBULLISH 64Analyst

Xencor price target raised to $40 from $29 at Truist

1d agoThe FlyBULLISH 67Analyst

Xencor price target raised to $45 from $30 at Wedbush

1d agoInvesting.com Analyst RatingsBULLISH 64Analyst

Wells Fargo raises Xencor stock price target on kidney cancer data

Wells Fargo raises Xencor stock price target on kidney cancer data

Frequently asked questions

Why is XNCR stock moving today?

XENCOR INC (XNCR) is drawing unusual attention today. Our newswire has captured 10 stories on XNCR across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 64/100). The most recent driver: "XENCOR Maintains Buy Rating -- Price Target Raised to $40.00 by Truist Securities" (GuruFocus).

Is XNCR a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of XNCR coverage reads 64/100 over 10 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.

More moves explained today

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on XNCR: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier XNCR move explainers: 2026-09-02